High-intensity focused ultrasound (HIFU) ablation for the treatment of prostate cancer
Ludwig Boltzmann Institute for HTA (LBI-HTA)
Record ID 32018001161
English
Authors' objectives:
This is the assessment of the relative effectiveness of high-intensity focused ultrasound (HIFU) ablation for the treatment of prostate cancer. The purpose of the assessment is to evaluate the relative effectiveness and safety of high-intensity focused ultrasound as primary therapy or as salvage therapy for the treatment of clinically localised or locally relapsed prostate cancer in comparison to deferred treatment strategies (active surveillance, watchful waiting) and/or standard radical treatment strategies (radical prostatectomy, radiation therapy).
Details
Project Status:
Completed
URL for project:
https://eunethta.eu/otca09-high-intensity-focused-ultrasound-hifu-ablation-for-the-treatment-of-prostate-cancer-is-now-available/
Year Published:
2018
URL for published report:
https://eunethta.eu/otca09-high-intensity-focused-ultrasound-hifu-ablation-for-the-treatment-of-prostate-cancer-is-now-available/
Requestor:
HTA agencies
English language abstract:
An English language summary is available
Publication Type:
Rapid Review
MeSH Terms
- High-Intensity Focused Ultrasound Ablation
- Prostatic Neoplasms
Contact
Organisation Name:
European Network for Health Technology Assessment
Contact Email:
eunethta@zinl.nl
Copyright:
CC-BY-NC: You may copy, distribute, display, perform, and modify and use the EUnetHTA work for any purpose other than commercially unless you get your permission first.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.